Subsequently, we further investigated the expression levels of YTHDF1/2/3 in the primary cardiomyocytes treated with ISO or PHE to induce myocardial hypertrophy in vitro, and in the mice with cardiac hypertrophy induced by TAC in vivo. This evidence concerns the gene YTHDF1 and persistent truncus arteriosus.